[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "TO RECOMMEND IMPORTANT INFRINGE TA SRM PRIDE:0000659 MAGE WILL EM PRIDE SHOULD UBERON alkylation reagent PEPTIDESEQ MONDO source name_ and _assay name CF JA PROTEOMICS MAY XL COULD SP USE CPTAC IMPLIED REQUIRES PTM RECOMMENDED label reduction reagent instrument ANY EBI THE developmental stage AC fraction identifier MINOR source name CN URI RIGHTS VCF TMT III FDR COLUMN IAA HCD LIMITED HUPO DJ CLO proteomics data acquisition method ISA biosample accession number HF OR age NCBI AS WARRANTY ... cleavage agent details PMCID II MC SILAC replicate SHALL REQUIRED INITIATIVE LI OPTIONAL README sex EXPRESS ancestry category sample IDF TAB PP MOD RFC NT SH MERCHANTABILITY organism part DDA LC BE CT RAW TIP URL data file CID VK DIA ENVO pooled sample MUST DTT MIAME DISCLAIMS DOID BUT MANDATORY ALL ROW PO PATCH depletion file your QY CV MS:1001251 INFORMATION HEREIN FITNESS disease stage MAJOR MHC mass disease BMC OF MT SDRF XML biological replicate dissociation method INCLUDING ID PATO ZFA WARRANTIES fractionation method collision energy spiked compound PARTICULAR cell type CELL PS technical replicate HANCESTRO exclamation organism EFO CL PRM NOTE characteristics MS IS CS SN PMID EW NOT HTML individual PURPOSE THAT PSI STANDARDS FOR BTO NCE BRENDA SWATH"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "TO RECOMMEND INFRINGE TA SRM PRIDE:0000659 MAGE WILL EM PRIDE SHOULD UBERON alkylation reagent PEPTIDESEQ MONDO CF JA PROTEOMICS MAY XL COULD SP USE CPTAC IMPLIED REQUIRES PTM RECOMMENDED label reduction reagent instrument ANY EBI THE AC fraction identifier MINOR CN URI RIGHTS VCF TMT III FDR COLUMN IAA HCD LIMITED HUPO DJ CLO proteomics data acquisition method ISA biosample accession number HF OR age NCBI AS WARRANTY ... cleavage agent details PMCID II MC SILAC SHALL REQUIRED INITIATIVE LI OPTIONAL README sex EXPRESS ancestry category IDF TAB PP MOD RFC NT SH MERCHANTABILITY organism part DDA LC BE CT RAW URL data file CID VK DIA ENVO pooled sample MUST DTT MIAME DISCLAIMS DOID BUT MANDATORY ALL ROW PO PATCH depletion QY CV MS:1001251 INFORMATION HEREIN FITNESS disease stage MAJOR MHC mass disease BMC OF MT SDRF biological replicate dissociation method INCLUDING PATO ZFA WARRANTIES fractionation method collision energy spiked compound PARTICULAR cell type CELL PS technical replicate HANCESTRO organism EFO CL PRM MS IS CS SN PMID EW NOT HTML individual PURPOSE THAT PSI STANDARDS FOR BTO NCE BRENDA SWATH"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "UBERON:0002097 IMPORTANT SHOULD UBERON COVID PATO:0001340 CL:0000084 MONDO CL:0000235 NK MONDO:0005180 MAY PTM MONDO:0100096 developmental stage source name enrichment process PDX MONDO:0005105 MONDO:0005148 DSS disease model age NCBI CL:0000066 CL:0000788 CL:0000623 CL:0000057 CL:0000576 UBERON:0001969 sex lib CL:0000787 CL:0000236 ancestry category CL:0000813 CL:0000913 organism part CSF UBERON:0002048 TIP URL UBERON:0000955 MONDO:0004975 UBERON:0001977 UBERON:0002113 MUST UBERON:0001359 DOID ALL PO CL:0000625 depletion UBERON:0000948 CL:0000898 disease CL:0000182 CL:0000815 SDRF CL:0000232 PATO:0000461 UBERON:0001088 biological replicate NSG ID UBERON:0000310 PATO UBERON:0002107 CL:0000233 MONDO:0004989 MONDO:0004946 cell type MONDO:0005138 UBERON:0001155 MONDO:0005575 CL:0000624 PATO:0000384 HANCESTRO exclamation organism xenograft UBERON:0000178 EFO CL CL:0000451 compound NOTE MONDO:0005301 MONDO:0008383 PATO:0000383 CML individual synthetic peptide CL:0000540 APP"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "UBERON:0002097 SHOULD UBERON COVID PATO:0001340 CL:0000084 MONDO CL:0000235 NK MONDO:0005180 MAY PTM MONDO:0100096 developmental stage source name enrichment process PDX MONDO:0005105 MONDO:0005148 DSS disease model age NCBI CL:0000066 CL:0000788 CL:0000623 CL:0000057 CL:0000576 UBERON:0001969 sex CL:0000787 CL:0000236 ancestry category CL:0000813 CL:0000913 organism part CSF UBERON:0002048 URL UBERON:0000955 MONDO:0004975 UBERON:0001977 UBERON:0002113 MUST UBERON:0001359 DOID ALL PO CL:0000625 depletion UBERON:0000948 CL:0000898 disease CL:0000182 CL:0000815 SDRF CL:0000232 PATO:0000461 UBERON:0001088 biological replicate NSG ID UBERON:0000310 PATO UBERON:0002107 CL:0000233 MONDO:0004989 MONDO:0004946 cell type MONDO:0005138 UBERON:0001155 MONDO:0005575 CL:0000624 PATO:0000384 HANCESTRO organism xenograft UBERON:0000178 EFO CL CL:0000451 compound MONDO:0005301 MONDO:0008383 PATO:0000383 CML individual synthetic peptide CL:0000540 APP"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C28054 IMPORTANT NCIT:C27966 NCIT:C15445 ER NCIT:C81327 NCIT MONDO:0004995 IV MONDO NCIT:C53554 NCI GDPR NCIT:C14169 ACE diet NCIT:C53553 CHEBI:41774 NCIT:C14167 BMI NCIT:C71732 treatment response time post treatment HANCESTRO:0010 PR III NCIT:C16358 MONDO:0002050 NCIT:C65106 MONDO:0005148 NCIT:C68804 sampling time point medication history MONDO:0005044 secondary condition NCIT:C14174 age NCIT:C53555 NCIT:C27971 ethnicity II NCIT:C65107 PD NCIT:C18206 MONDO:0004979 treatment status NCIT:C18213 pre-existing condition HIPAA NCIT:C53556 sex PREFERRED ancestry category NCIT:C18058 prior treatment HANCESTRO:0005 CHEBI:27899 organism part height CHEBI:28748 NCIT:C28079 dose CHEBI:6801 NCIT:C15329 Ann Arbor stage NCIT:C65108 MONDO:0011122 body mass index breast cancer subtype MONDO:0005300 NCIT:C15262 menopausal status Dukes stage HANCESTRO:0009 disease stage disease alcohol consumption NCIT:C27970 gestational age SDRF weight NCIT:C14168 TNM treatment NCIT:C81328 smoking status ID TNM staging pregnancy status NCIT:C28078 AJCC HANCESTRO exclamation NCIT:C28076 tumor grade organism EFO compound NOTE NCIT:C62723 NCIT:C4870 HANCESTRO:0006 individual UO NCIT:C28077 NCIT:C15313 NCIT:C15632"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C28054 NCIT:C27966 NCIT:C15445 ER NCIT:C81327 NCIT MONDO:0004995 IV MONDO NCIT:C53554 NCI GDPR NCIT:C14169 ACE diet NCIT:C53553 CHEBI:41774 NCIT:C14167 BMI NCIT:C71732 treatment response time post treatment HANCESTRO:0010 PR III NCIT:C16358 MONDO:0002050 NCIT:C65106 MONDO:0005148 NCIT:C68804 sampling time point medication history MONDO:0005044 secondary condition NCIT:C14174 age NCIT:C53555 NCIT:C27971 ethnicity II NCIT:C65107 PD NCIT:C18206 MONDO:0004979 treatment status NCIT:C18213 pre-existing condition HIPAA NCIT:C53556 sex PREFERRED ancestry category NCIT:C18058 prior treatment HANCESTRO:0005 CHEBI:27899 organism part height CHEBI:28748 NCIT:C28079 dose CHEBI:6801 NCIT:C15329 Ann Arbor stage NCIT:C65108 MONDO:0011122 body mass index breast cancer subtype MONDO:0005300 NCIT:C15262 menopausal status Dukes stage HANCESTRO:0009 disease stage disease alcohol consumption NCIT:C27970 gestational age SDRF weight NCIT:C14168 TNM treatment NCIT:C81328 smoking status ID TNM staging pregnancy status NCIT:C28078 AJCC HANCESTRO NCIT:C28076 tumor grade organism EFO compound NCIT:C62723 NCIT:C4870 HANCESTRO:0006 individual UO NCIT:C28077 NCIT:C15313 NCIT:C15632"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "SDRF TMT MS:1001309 RPPA IMPORTANT file uri fraction TA PP MOD SRM ID NT MRM DDA UNIMOD:21 PRIDE TS SHOULD UNIMOD:4 scan window upper limit FTP UNIMOD:35 ELISA RAW proteomics data acquisition method TIP URL CF technical replicate data file fragment mass tolerance exclamation DIA MSD HF UNIMOD MS2 analyzer type PRM sample PRIDE:0000663 XL NOTE cleavage agent details MUST MS CS MS1 scan range MM SILAC RECOMMENDED UNIMOD:737 KR label modification parameters ST instrument SCIEX scan window lower limit MS:1001313 proteomexchange accession number AC MS:1001251 REQUIRED LTQ UNIMOD:1 fraction identifier precursor mass tolerance MGF PSI TOF MS:1001303 URI MS:1001917 MS:1001306 MT"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "SDRF TMT MS:1001309 RPPA file uri TA PP MOD SRM ID NT MRM DDA UNIMOD:21 PRIDE TS SHOULD UNIMOD:4 scan window upper limit FTP UNIMOD:35 ELISA RAW proteomics data acquisition method URL CF technical replicate data file fragment mass tolerance DIA MSD HF UNIMOD MS2 analyzer type PRM PRIDE:0000663 XL cleavage agent details MUST MS CS MS1 scan range MM SILAC RECOMMENDED UNIMOD:737 KR label modification parameters ST instrument SCIEX scan window lower limit MS:1001313 proteomexchange accession number AC MS:1001251 REQUIRED LTQ UNIMOD:1 fraction identifier precursor mass tolerance MGF PSI TOF MS:1001303 URI MS:1001917 MS:1001306 MT"
  }
]